The Hematologist

In her Diffusion article from the May/June 2017 issue of The Hematologist, Dr. Sioban Keel looks at genetic profiling to guide stem-cell transplantation in myelodysplastic syndromes. She covers a New England Journal of Medicine article co-authored by Dr. Benjamin Ebert. In this podcast, Dr. Ebert joins Dr. Keel for a thought-provoking conversation. You can find the article online at www.hematology...

In this podcast, ASH Awards Committee members, Drs. Linda Burns and Mohandas Narla discuss ASH's most prestigious awards, the Honorifics. They provide a thorough overview of the seven awards, the nomination process, as well as the importance of nominating your colleagues to be honored for their achievements. These awards recognize hematologists for accomplishments that serve as building blocks for...

In her Clinical Trials Corner article from the March/April 2017 issue of The Hematologist, Dr. Elizabeth Raetz along with Dr. Tibor Kovacsovics take a look at the Beat AML Trial. In this podcast, and through ASH's partnership with the Leukemia and Lymphoma Society, AML experts Dr. John Byrd and Dr. Eytan Stein join Dr. Raetz in a conversation about the trial's design, rationale, and results, as we...

The first podcast of 2017 for The Hematologist: ASH News and Reports features Dr. Jason Gotlib (Stanford University School of Medicine) and Dr. Alexis Thompson (Ann and Robert H. Lurie Children's Hospital) having a conversation about the highlights of 2016 in sickle cell disease (SCD). They cover studies in SCD and ASH Sickle Cell Disease initiatives in order to demonstrate why it is such an excit...

In this special podcast, Dr. Aaron Gerds (Cleveland Clinic) has a conversation with Dr. Laurie Sehn (University of British Columbia/BC Cancer Agency) about exciting events that will be taking place at this year's ASH annual meeting, which will take place December 3 to 6 in San Diego, California. The meeting will feature an array of education and scientific sessions, and oral and poster presentatio...

In his Diffusion article from the November/December issue of The Hematologist, Dr. Michael DeBaun (Vanderbilt University) discusses the need for further research in efforts to update and implement universal procedures to prevent unnecessary death and acute illness for college and high school athletes with SCD. He covered the article by Dr. Lianne Kurina (Stanford University) and colleagues titled...

In this special podcast, Dr. Gary Gilliland from Fred Hutch and Drs. Ross Levine and Omar Abdel-Wahab from Memorial Sloan Kettering, talk about the significance of the ASH Scholar Award in their careers. This podcast, which follows the theme of “Three Generations of Scholar Award Recipients,” celebrates 30 years of the ASH Scholar Awards designed to support hematologists who have chosen a career i...

In our ninth podcast for The Hematologist, Dr. Tracy George (University of New Mexico School of Medicine) and Dr. Rama Gullapalli (University of New Mexico School of Medicine) have a conversation with Dr. Jason Gotlib (Stanford University School of Medicine) about lessons for clinicians and pathologists, learned from the Theranos controversy. The podcast covers the Op-Ed written by Drs. George and...

In this special podcast, Dr. Ken Anderson and Dr. Martin Tallman, program co-chairs for the Meeting on Hematologic Malignancies, talk about the exciting events that will be taking place at this year’s meeting, which will take place September 16 to 17 at the Fairmont Chicago in Millennium Park, Chicago, Illinois. Attendees will have the opportunity to hear world-class experts in hematologic maligna...

In his Diffusion article from the July/August issue of The Hematologist, Dr. Adam Cuker (University of Pennsylvania) covers options to reduce the incidence of heparin-induced thrombocytopenia (HIT), treating it as a preventable nosocomial disease rather than an unavoidable iatrogenic disorder. He looks at the study “Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avo...

In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Dr. Andrew Roberts (Walter + Eliza Hall Institute of Medical Research) shares his thoughts about the drug and his...

In his Diffusion article from the March/April issue of The Hematologist, Dr. Michael DeBaun (Vanderbilt University School of Medicine) takes a look at the TWiTCH Trial, a multicenter, open-label, phase III, non-inferiority trial. Dr. Russell Ware (University of Cincinnati and Cincinnati Children's Hospital), the national Principal Investigator for this NIH-funded trial conducted under the sponsors...

In her Diffusion article from the November/December issue of The Hematologist, Dr. Pamela Becker (Institute for Stem Cell and Regenerative Medicine and Center for Cancer Innovation, University of Washington, Seattle, WA) talks about the many mutations identified in acute myeloid leukemia (AML) and the efforts of investigators to find a practical application of this information in modifying treatme...

In his Diffusion article from the September/October issue of The Hematologist, Dr. Adam Cuker (Penn-CHOP Blood Center for Patient Care and Discovery, University of Pennsylvania, Philadelphia, PA) discusses the BRIDGE study, which was led by Dr. Thomas Ortel (Duke University Medical Center, Durham, NC). Dr. Cuker concludes that, while more data are needed, there may be high-risk patients or procedu...

In his recent Diffusion article from the July/August issue of The Hematologist, Dr. David Garcia (University of Washington School of Medicine, University of Washington Medical Center, Seattle, WA) discusses the PREPIC2 study. The PREPIC2 results, published in JAMA, highlight the benefits of well-managed anticoagulation in patients with high-risk pulmonary embolism. In this podcast, Dr. Garcia shed...

The strategic roadmap developed at the original ASH Meeting on Lymphoma Biology held in August 2014 was recently published in Blood. To continue this important conversation, Dr. Ann LaCasce (Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA) and Dr. David Weinstock (Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA) have contributed a companion article, just published...